Search

everythinglearnresearchcommunity

for

Search:↓

Watching, not removing, skin growths with moderate atypia and positive edges is okay; patients may get melanoma elsewhere, especially if they've had it before.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Early treatment of acne is crucial to prevent scarring and psychological effects.

308 nm excimer light therapy may help hair regrowth in alopecia areata with delayed results and no serious side effects.

Adalimumab can cause complete hair loss in rare cases.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Non-adherence to medication in Egyptian SLE patients leads to more hospitalizations and symptoms.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Belimumab effectively controls SLE disease activity and reduces steroid use.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Baricitinib may effectively treat nail changes in alopecia areata.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Using medicinal plants traditionally helps in their preservation in Charmang Village, Pakistan.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Effective treatments for severe alopecia areata are still lacking.